Questions About Cancer? 1-800-4-CANCER

Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)

Health Professional Version
Last Modified: 07/17/2014

Changes to This Summary (07/17/2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Multiple Endocrine Neoplasia Type 2

Added text to state that 20% to 41% of patients with apparently sporadic pheochromocytoma have a mutation in one of the susceptibility genes (cited Jafri et al. as reference 50).

Familial Paraganglioma Syndrome

Added Preoperative management as a new subsection.

Added Surgical interventions as a new subsection.

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.